AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Aker BioMarine

Capital/Financing Update Aug 29, 2024

3527_rns_2024-08-29_108315ae-f6e4-43b5-8d57-6b20d160aa68.html

Capital/Financing Update

Open in Viewer

Opens in native device viewer

Aker BioMarine ASA – Successful placement of senior secured bonds

Aker BioMarine ASA – Successful placement of senior secured bonds

29 August 2024: Aker BioMarine ASA ("AKBM") has successfully completed a new bond issue of NOK 1,600 million, carrying a coupon of 3 months NIBOR +4.25% p.a. with quarterly interest payments. The bond issue was oversubscribed.

The net proceeds from the bond issue, together with proceeds from the sale of the Feed Ingredients business, will be employed towards refinancing of existing debt, distributing an extraordinary dividend and general corporate purposes.

Arctic Securities, DNB Markets and Nordea acted as Joint Lead Managers in connection with the placement of the new bond issue.

For further information, please contact

Christopher Robin Vinter, VP IR & Corporate Finance

Mobile: +47 911 60 820

Email: [email protected]

About Aker BioMarine

Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

Talk to a Data Expert

Have a question? We'll get back to you promptly.